ZYTIGA is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with • metastatic castration-resistant prostate cancer (CRPC). • metastatic high-risk castration-sensitive prostate cancer (CSPC).
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of ZYTIGA (abiraterone acetate) tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ZYTIGA (abiraterone acetate) tablets cost price in India.
The order for ZYTIGA (abiraterone acetate) tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Abiraterone, also known as abiraterone acetate and sold under the brand name Zytiga among others, is a medication used to treat prostate cancer. Specifically it is used together with corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). It should either be used following removal of the testicles or along with a gonadotropin-releasing hormone (GnRH) analog.
ZYTIGA® (abiraterone acetate) tablets, for oral use Initial U.S. Approval: 2011
Generic Name: abiraterone acetate
Film-Coated Tablet 500 mg
• Uncoated Tablet 250 mg
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ZYTIGA (abiraterone acetate) tablets on prescription and Import License in Patient's Name only.
For overseas patients, ZYTIGA (abiraterone acetate) tablets can be made available in Send your enquiry to find ZYTIGA (abiraterone acetate) tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For ZYTIGA (abiraterone acetate) tablets Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Zytiga Prescribing Information Updated With New Warnings For More Details
Generic Zytiga Approval for Prostate Cancer Tops SPT Week in ReviewReadMore